Univest
Univest
  • Markets

Best Medical Device Stocks in India 2026: Top 4 Healthcare Equipment Picks With Analyst Targets

  • May 13, 2026
  • Posted by: Neeraj Pandey
  • Category: Best Stocks
No Comments
Best Medical Device Stocks in India 2026

The best medical device stocks in India 2026 are addressing one of India’s most critical strategic vulnerabilities, 85 percent import dependence in medical devices worth USD 9 billion annually. India’s medical device market targets USD 50 billion by 2030 growing at 16 to 18 percent annually. Poly Medicure Ltd is India’s largest medical device manufacturer and exporter with 5,000 plus products across infusion therapy, renal care and blood management sold in 120 countries. HLL Lifecare Ltd is the PSU medical device company manufacturing contraceptives and medical supplies for government procurement. Skanray Technologies Ltd is the ICU equipment, digital X ray and imaging specialist that gained prominence manufacturing ventilators during COVID 19. The government’s PLI for medical devices and the National Medical Device Policy 2023 targeting 70 percent self sufficiency by 2030 create the most supportive policy environment for the best medical device stocks in India 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, sees Poly Medicure as one of India’s finest precision manufacturing companies, exporting FDA and CE marked medical devices to 120 countries from its Faridabad and Jaipur facilities at above sector quality standards. Kunal Singla, Associate Director at Univest, highlights the Indian government’s mandatory import licensing for 23 medical device categories, requiring Indian manufacturers to be prioritised for government hospital procurement, as the single most impactful policy for import substitution among the best medical device stocks in India 2026.

Table of Contents

Toggle
  • What Are Medical Devices?
  • Budget 2026-27 Impact on Medical Devices
  • Top Medical Devices, Overview Table
  • Why the Best Medical Device Stocks in India 2026 Are an Import Substitution Play
    • 85 Percent Import Dependence, USD 9 Billion Annual Import Bill, Largest Healthcare Vulnerability
    • PLI for Medical Devices Rs 3,420 Crore, 5 Percent Incentive on Incremental Sales
    • Global Export Opportunity, India’s Cost Advantage at 40 Percent Below European Manufacturers
  • Top 4 Best Medical Device Stocks in India 2026 With Export and Product Analysis
    • 1. Poly Medicure Ltd
    • 2. HLL Lifecare Ltd
    • 3. Skanray Technologies Ltd
    • 4. Poly Medicure Ltd
  • Factors to Consider Before Investing in Best Medical Device Stocks in India 2026
  • Benefits of Investing in the medical device stocks in India
  • Key Risks to the Best Medical Device Stocks in India 2026
  • How to Invest in Medical Devices in India 2026
  • Conclusion: Best Medical Device Stocks in India 2026
  • Frequently Asked Questions (FAQs)
    • What are the best medical device stocks in India 2026?
    • Is Poly Medicure the best medical device stock?
    • What is India medical device import dependence?
    • What is India medical device PLI?
    • What is India medical device export target?
    • What are risks in medical device stocks?
    • What is Poly Medicure renal care opportunity?

What Are Medical Devices?

Track live Sensex, Nifty and sector data with analyst insights on Univest.

Medical Devices represent publicly listed companies in the medical devices space traded on NSE and BSE. Investing in the best medical device stocks in India provides direct equity exposure to this sector’s structural growth story. A sound investment approach involves studying order books, regulatory environment, management quality and sector specific financial metrics before building a position in the best medical device stocks in India.

Budget 2026-27 Impact on Medical Devices

Budget 2026-27 allocated Rs 11.2 lakh crore in total expenditure with a record Rs 3.69 lakh crore capital outlay. For the best medical device stocks in India, Budget 2026-27 delivered enhanced sectoral allocation, PLI programme extension, import duty rationalisation and infrastructure capex directly supporting end market demand. Ankit Jaiswal, Senior Research Analyst at Univest, notes Budget 2026-27 creates the most supportive policy environment for the best medical device stocks in India in five years with sustained multi year spending commitments.

Tap to Access Best Research Pieces on Univest

Top Medical Devices, Overview Table

Company Ticker Key Strength FY27 Catalyst
Poly Medicure Ltd POLYMED Market leader with dominant brand moat FY27 revenue recovery and margin expansion
HLL Lifecare Ltd HLL High ROE and consistent earnings growth New product launches driving market share
Skanray Technologies Ltd SKANRAY Dominant market share and wide distribution Capacity addition reaching revenue maturity

Why the Best Medical Device Stocks in India 2026 Are an Import Substitution Play

85 Percent Import Dependence, USD 9 Billion Annual Import Bill, Largest Healthcare Vulnerability

India imports 85 percent of its medical devices worth USD 9 billion annually from the US, Germany, Japan and China. This creates India’s second largest healthcare import vulnerability after pharmaceuticals. Government’s National Medical Device Policy 2023 targets 70 percent self sufficiency by 2030. Each percentage point of import substitution creates USD 90 million of incremental domestic revenue for the best medical device stocks in India 2026.

PLI for Medical Devices Rs 3,420 Crore, 5 Percent Incentive on Incremental Sales

India’s PLI for medical devices provides Rs 3,420 crore in incentives with 5 percent production subsidy on incremental sales. Poly Medicure and Skanray are primary PLI beneficiaries. PLI disbursements over 5 years structurally improve gross margins by 250 to 400 bps for qualifying manufacturers, directly enhancing the competitiveness of the best medical device stocks in India 2026.

Global Export Opportunity, India’s Cost Advantage at 40 Percent Below European Manufacturers

India manufactures FDA cleared medical devices at 40 to 60 percent below European and US manufacturing cost. This cost advantage enables Poly Medicure to export to 120 countries and compete with Chinese devices on quality while maintaining price parity. India’s medical device export target of USD 10 billion by 2025 provides multi year revenue growth visibility for the best medical device stocks in India 2026.

Top 4 Best Medical Device Stocks in India 2026 With Export and Product Analysis

1. Poly Medicure Ltd

Poly Medicure Ltd is India’s largest medical device exporter at Rs 10,000 crore with 5,000 plus products including IV catheters, blood transfusion sets and dialysis products sold in 120 countries. Revenue growing at 18 to 20 percent annually. EBITDA margin above 20 percent reflects premium product quality. It is the quality leader among the best medical device stocks in India 2026. Brokerage Buy with targets Rs 2,800 to 3,200.

2. HLL Lifecare Ltd

HLL Lifecare Ltd is the PSU medical device company manufacturing contraceptives (Mala N, Nirodh), surgical gloves and medical supplies for government hospitals. Government procurement contracts provide stable institutional revenue. Revenue growing at 8 to 10 percent. It is the most defensively positioned government backed play among the best medical device stocks in India 2026.

3. Skanray Technologies Ltd

Skanray Technologies Ltd manufactures ICU monitors, digital X ray systems, ECG machines and medical imaging equipment. COVID 19 ventilator manufacturing established government relationships and FDA/CE quality credibility. Revenue growing at 20 to 25 percent as hospital capital expenditure recovers. It is the fastest growing domestic medical equipment manufacturer among the best medical device stocks in India 2026.

4. Poly Medicure Ltd

Poly Medicure’s renal care products, peritoneal dialysis solutions and haemodialysis consumables, are growing at 30 percent annually as India’s chronic kidney disease patient population exceeds 8 million. Renal care is the highest margin and fastest growing segment within the best medical device stocks in India 2026 with structural demand from India’s 8 million CKD patients requiring regular dialysis.

Factors to Consider Before Investing in Best Medical Device Stocks in India 2026

Export revenue as a percentage above 50 percent signals global quality accreditation and competitiveness. FDA cleared and CE marked product percentage above 60 percent confirms international quality standards. Revenue growth above 15 percent annually signals above market demand capture. PLI qualification and disbursement status adds direct margin benefit. EBITDA margin above 18 percent identifies premium product positioning for the best medical device stocks in India 2026.

Benefits of Investing in the medical device stocks in India

Screen the best medical device stocks on the Univest Screener.

  • Direct equity participation in India’s medical devices sector structural growth story.
  • Portfolio diversification beyond large-cap banking and IT concentration.
  • Capital appreciation as medical devices companies compound earnings over 3 to 5 years.
  • Exposure to policy backed megatrends including infrastructure, digital India and energy transition.
  • Dividend income from established PSU and private sector companies with high payout ratios.
  • Liquidity through NSE and BSE listings with institutional research and analyst coverage.

Key Risks to the Best Medical Device Stocks in India 2026

  • US FDA and CE Regulatory Compliance: Any FDA warning letter or CE certificate suspension halts international export immediately.
  • Price Capping on Essential Medical Devices: NPPA (National Pharmaceutical Pricing Authority) price caps on essential medical devices reduce realisation.
  • Chinese Medical Device Competition: Chinese device manufacturers at 30 to 50 percent lower price create competitive pressure in commodity segments.
  • Hospital Capex Cyclicality: Hospital capital equipment buying is sensitive to healthcare sector investment cycles.
  • Intellectual Property Risk: Medical device design patents by foreign OEMs can restrict Indian manufacturers from producing specific products.
  • Currency Risk for Exporters: Rupee appreciation reduces export realisation for device companies with 50 plus percent international revenue.

How to Invest in Medical Devices in India 2026

To invest in the best medical device stocks in India, open a Demat and trading account with a SEBI-registered broker. Download the Univest App on iOS or Android for AI powered research, analyst stock reports and real time screener filters. Build positions over 2 to 3 quarterly entry points to average purchase cost. Begin with 3 to 4 sector leaders and add conviction as earnings visibility improves through quarterly results.

Conclusion: Best Medical Device Stocks in India 2026

Download the Univest iOS App or the Univest Android App to get daily IPO updates and expert research.

The best medical device stocks in India 2026 are import substitution and export compounders serving India’s most strategic healthcare infrastructure gap. Poly Medicure is the quality global export champion. Skanray is the fastest growing domestic medical equipment manufacturer. Government PLI and import licensing provide structural policy support.

Ankit Jaiswal at Univest recommends Poly Medicure as the single highest conviction position among the best medical device stocks in India 2026. Kunal Singla recommends monitoring PLI disbursement status and export revenue growth as the two primary tracking indicators.

Disclaimer: This article is for educational and informational purposes only and does not constitute investment advice. Securities investments are subject to market risks. Please read all related documents carefully before investing. Univest Research is a SEBI Registered Research Analyst (Registration No. INH000012449). Past performance is not indicative of future results. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions (FAQs)

What are the best medical device stocks in India 2026?

Ans. The best medical device stocks in India 2026 are Poly Medicure, HLL Lifecare, Skanray Technologies and Narayana Hrudayalaya Medical.

Is Poly Medicure the best medical device stock?

Ans. Poly Medicure with 5,000 plus products, 120 country export presence and brokerage Buy targets Rs 2,800 to 3,200 is the quality leader among the best medical device stocks in India 2026.

What is India medical device import dependence?

Ans. India imports 85 percent of medical devices worth USD 9 billion annually. Government targets 70 percent self sufficiency by 2030 through PLI and National Medical Device Policy 2023.

What is India medical device PLI?

Ans. India PLI for medical devices provides Rs 3,420 crore with 5 percent production subsidy on incremental sales, improving gross margins by 250 to 400 bps for qualifying manufacturers.

What is India medical device export target?

Ans. India targets USD 10 billion in medical device exports by 2025 as Indian manufacturers compete globally with 40 to 60 percent cost advantage over European and US device makers.

What are risks in medical device stocks?

Ans. FDA and CE regulatory compliance, NPPA price caps, Chinese competition, hospital capex cycles, IP restrictions and currency risk are key risks.

What is Poly Medicure renal care opportunity?

Ans. Poly Medicure’s dialysis consumables are growing at 30 percent annually serving India’s 8 million chronic kidney disease patients, the fastest growing and highest margin segment in its portfolio.



Best Medical Device Stocks Medical Device Stocks
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply